Fingerprint
Dive into the research topics of 'Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation
Yuan Hung Kuo, Jing Houng Wang, Chao Hung Hung, Sheng Nan Lu, Tsung Hui Hu*, Chien Hung Chen*
*Corresponding author for this work
Research output: Contribution to journal › Journal Article › peer-review
22
Scopus
citations